SSX7 antibody (N-Term)

Catalog No. ABIN1881839

There are 2+ publications for this product available. The Rabbit Polyclonal anti-SSX7 antibody is suitable to detect SSX7 in samples from Human. It has been validated for WB.

Quick Overview for SSX7 antibody (N-Term) (ABIN1881839)

Target: SSX7 (Synovial Sarcoma, X Breakpoint 7 (SSX7))

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This SSX7 antibody is un-conjugated

Application: Western Blotting (WB)

Clone: RB41797

Product Details anti-SSX7 Antibody

Binding Specificity: AA 1-30, N-Term

Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogen: This SSX7 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1-30 amino acids from the N-terminal region of human SSX7.

Isotype: Ig Fraction

Application Details

Application Notes: WB: 1:1000

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C,-20 °C

Expiry Date: 6 months

References for anti-SSX7 antibody (ABIN1881839)

Güre, Wei, Old, Chen: "The SSX gene family: characterization of 9 complete genes." in: International journal of cancer. Journal international du cancer, Vol. 101, Issue 5, pp. 448-53, (2002) (PubMed).

Chen, Chen, Lee, Huang, Yang, Tsai, Chen, Sheu: "Expressions of cancer-testis antigens in human hepatocellular carcinomas." in: Cancer letters, Vol. 164, Issue 2, pp. 189-95, (2001) (PubMed).

Target Details for SSX7

Target: SSX7 (Synovial Sarcoma, X Breakpoint 7 (SSX7))

Alternative Name: SSX7

Background: The product of this gene belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X,18) translocation characteristically found in all synovial sarcomas. This gene appears not to be involved in this type of chromosome translocation.

Molecular Weight: 21591

NCBI Accession: NP_775494

UniProt: Q7RTT5